dalutrafusp alfa
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for dalutrafusp alfa, covering 2023-11-21 to 2023-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors [Phase 1]